Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease
- 1 December 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 348 (9041) , 1555-1559
- https://doi.org/10.1016/s0140-6736(96)04451-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- Quantitative Analysis of the Targeting of Mannose‐Terminal GlucocerebrosidaseEuropean Journal of Biochemistry, 1996
- A biochemical and immunocytochemical study on the targeting of alglucerase in murine liverJournal of Molecular Histology, 1995
- Studies on the turnover of exogenous mannose‐terminal glucocerebrosidase in rat liver lysosomesJournal of Cellular Biochemistry, 1995
- Recognition of complex carbohydrates by the macrophage mannose receptorBiochemical Society Transactions, 1993
- Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.Journal of Clinical Investigation, 1993
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylationBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Human β-glucuronidase: In vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cellsCell, 1978